Bottom line
IHI vs RSPH: the short answer
IHI (iShares U.S. Medical Devices ETF) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
IHI is cheaper at 0.37% vs 0.4% — a difference of $3.00 a year per $10,000 invested.
Over five years, RSPH returned +4.7% a year vs +3.1% for IHI.
Updated Nov 19, 2026
IHI vs RSPH side by side
| IHI | RSPH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.4% |
| Annual cost per $10k | $37 | $40 |
| 10-yr cost on $10k (prospectus) | $468 | $505 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +6.9% | +9.3% |
| 5-yr return (annualized) | +3.1% | +4.7% |
| 10-yr return (annualized) | +12.2% | +8.2% |
| Best quarter | +17.6% | +17.5% |
| Worst quarter | −17.2% | −14.3% |
| Net assets (fund) | $3.0B | $766.9M |
| Number of holdings | 50 | 63 |
| Portfolio turnover | 12% | 24% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHI | RSPH | Difference |
|---|---|---|---|
| 2025 | +6.9% | +9.3% | −2.5% |
| 2024 | +8.6% | −0.8% | +9.4% |
| 2023 | +3.2% | +3.9% | −0.7% |
| 2022 | −19.7% | −9.2% | −10.5% |
| 2021 | +21.0% | +23.0% | −2.0% |
| 2020 | +24.2% | +18.9% | +5.3% |
| 2019 | +32.7% | +25.3% | +7.4% |
| 2018 | +15.5% | −0.3% | +15.8% |
| 2017 | +30.9% | +23.4% | +7.5% |
| 2016 | +9.2% | −4.5% | +13.7% |
Source: Fund prospectus bar charts
Holdings overlap
6 of IHI's top 25 holdings also appear in RSPH's top 25.
| Holding | IHI | RSPH |
|---|---|---|
| Abbott Laboratories | 16.93% | 1.83% |
| Becton, Dickinson And Company | 4.63% | 1.73% |
| Dexcom, Inc. | 4.02% | 1.73% |
| Steris Public Limited Company | 3.20% | 1.70% |
| Baxter International Inc. | 1.71% | 1.99% |
| Insulet Corporation | 1.63% | 1.70% |
Source: SEC Form N-PORT
IHI top 10
- Abbott Laboratories — 16.93%
- Intuitive Surgical, Inc. — 15.09%
- Stryker Corporation — 11.64%
- Edwards Lifesciences Corporation — 4.75%
- Becton, Dickinson And Company — 4.63%
- Ge Healthcare Technologies Inc. — 4.51%
- Medtronic Public Limited Company — 4.40%
- Resmed Inc. — 4.38%
- Idexx Laboratories, Inc. — 4.27%
- Dexcom, Inc. — 4.02%
RSPH top 10
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Regeneron Pharmaceuticals, Inc. — 1.96%
- Mettler-Toledo International Inc. — 1.94%
- Charles River Laboratories International, Inc. — 1.93%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
FAQ
What is the difference between IHI and RSPH?
Which is cheaper, IHI or RSPH?
Should I own both IHI and RSPH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.